typeface
large
in
Small
Turn off the lights
Previous bookshelf directory Bookmark Next

Chapter 437 Stage Results

"Wenxiu, Mom did something wrong before. If it can be undone, it will be fine even if Mom goes to Tanshan to beg Qin Chuan. But they are all married now, why don't you give up?" Wang Xiaoli was extremely anxious and couldn't help but say again.

It was a name that she really didn't want to hear or see mentioned. But this name kept appearing in her ears in the past few years.

Shang Wenxiu said helplessly: "Mom, it's not what you think at all. How could I still have any thoughts about him after so many years? Although there are some things that can't be truly let go just because you want to.

But it’s no longer possible for me to be with him. It’s just that I can’t accept others at the moment. I’m a little tired, and I will return to China in a while.”

"Are you coming back?" Wang Xiaoli asked in surprise.

"What? You don't want me to come back?" Shang Wenxiu pouted.

"How could it be? Your father and I are looking forward to your return every day. However, the doctor-patient relationship in China is not very good now. Your development abroad is much better than at home." Wang Xiaoli was a little happy, but also a little worried.

"It's okay. It's not like I've never worked in China. After all, those medical troubles are an isolated phenomenon. It's not uncommon abroad. There have also been incidents of shooting doctors to death abroad." Shang Wenxiu said.

"Ah, then you'd better come back." Wang Xiaoli said quickly.

*******

Qin Chuan would sometimes think of the two women who had briefly crossed paths in his life, but only to the extent that he thought of them. Now that Qin Chuan had a family and was an expectant father, he would naturally not have any more thoughts.

Distractions.

Qin Chuan's life is hurried and fulfilling. In the R&D center, he has to be a provider of advanced technology. At home, he has to be a good son, son-in-law and husband, and he will also be a good father in the future.

Jiang Lingling does not have much career ambition. She has now devoted all her energy to the child in her belly. She used to be a nurse and now she is a doctor. Jiang Lingling naturally knows very well what the child is like in the belly. She knows.

The more it is, the more difficult it is to let go. I am afraid of oppressing the fetus, and I am afraid that the fetus will not be in a good position. We also need to maintain a good mood so that the fetus can feel happy in the belly.

Even during this period of time, Jiang Lingling somewhat ignored Qin Chuan. Of course, careful mothers-to-be would often wake up. The marriage apologetically said to Qin Chuan: "Chuan, I'm sorry. During this period of time, I have been too nervous about our son. Isn't that right?

Have you been ignored a little?"

Qin Chuan's entire mind was focused on his child, so he didn't notice it. Even if he did, he wouldn't mind: "What to say. The most important thing now is our son."

"Well, don't be too busy. I know that your heart speeds up in the R&D center. You must be very tired because you are so busy." Only then did Jiang Lingling notice that she had not noticed that her husband was thin at all.

Made a circle.

"Why are you tired? I was too idle before. Although I will be a little busier this time, I will be idle when these teams are on the right track. I just want to do more things by then. I'm afraid I won't have the chance."

Qin Chuan smiled and stroked Jiang Lingling's slightly messy hair.

"Then don't tire yourself out." Jiang Lingling warned.

With the addition of Sun Chaokun's intelligent technology team, the progress of Kang Mo's team has accelerated a lot. After all, Kang Mo's team does not know much about intelligent statistical software. Now that professionals have joined, the research progress will naturally be much faster.

After the two teams worked together for half a month, Qin Chuan got good news.

"Dr. Qin, our two teams have achieved results. We have successfully developed a special Chinese medicine formula for treating Mers virus. After being made into a Chinese patent medicine, the effect is very ideal and the ability to inhibit the virus is very strong." Kang Mo said.

Although there are already monoclonal antibodies for Mers virus, the cost of monoclonal antibodies is high and the price is naturally not low. Moreover, the effect on mutant strains of Mers virus is extremely limited. In terms of application scope, it is not even as good as what Qin Chuan gave in the early stage.

Chinese medicine formula.

Therefore, Qin Chuan is more concerned about the adaptability of this new drug. "What is the effect on mers1?"

"Very good. We have tried several mers mutation types, and they all have very good inhibitory effects. The effect is much better than the previous free formula. It has special effects." Kang Mo was very excited.

"In this case, notify the R&D department to conduct clinical trials and launch it to the market as soon as possible. Your focus is still on the intelligent formulation of traditional Chinese medicine. You must take advantage of the cooperation between the two teams to solve the technical problems. It will not be so good in the future.

Here's a chance." Qin Chuan said.

Qin Chuan is still very concerned about the progress of Kang Mo's team. After all, he still has an unfinished system task. Now, he finds that he has become more and more exposed to the core of traditional Chinese medicine. The main purpose of the system issuing such a task is

Naturally, we will promote traditional Chinese medicine. It shows that even in the future, traditional Chinese medicine will still play a very important role.

The biggest problem with Chinese medicine is that Chinese medicine often treats one person and one disease. Unlike Western medicine, there is a programmed treatment process for the same disease. The prescriptions are almost always fixed. In this way

, very conducive to the teaching of technology. But Chinese medicine is different. Chinese medicine should prescribe medicine according to the specific situation of the patient. For the same disease, or even the same patient, it is almost impossible for different Chinese medicine doctors to prescribe the same medicine. Although Chinese medicine looks like

It is more tailored to local conditions and varies from person to person. However, it limits the development of traditional Chinese medicine.

The intelligent formula system may be able to solve this problem of traditional Chinese medicine. It can take the patient's various physical indicators into the formula, and also comprehensively consider the combination of various drugs to provide the best formula. Once this system is completely finalized

, may open up a new path for the development of traditional Chinese medicine.

Soon, the news that Handing Group developed a special Chinese patent medicine for Mers virus was reported in major domestic media. Domestic Chinese medicine practitioners were very excited. From the beginning of the spread of Mers virus, Handing Group released free formulas, and now it has developed

The development of special Chinese patent medicines is a very big progress. Traditional Chinese medicine has played an extremely important role in the fight against Mers.

The Koreans introduced a batch of monoclonal antibodies from Handing Group, but found that this monoclonal antibody is very effective against the general Mers virus, but has extremely limited effect against some mutant types. In addition, the virus continues to spread in South Korea, and quarantine

The number of people is increasing, and a large amount of vaccines have to be purchased from Handing. However, there is still nothing to do for patients who have been infected with variants. As the number of variants increases, the effect of vaccines gradually becomes extremely limited.

"Why have the Chinese developed a special medicine again, but our researchers are still helpless?" South Korea's female president was very dissatisfied with her country's medical experts.

Koreans' share of the international traditional Chinese medicine market has long surpassed that of China. Most of China's share is based on the export of raw materials of traditional Chinese medicine. But now, the research progress on special Chinese patent medicines for Mers obviously lags behind China, which makes

Koreans have to pay high prices to import treatment drugs from China. How can Koreans, who have always been obsessed with face, lose face?

"Handing Group has suddenly emerged in recent years. Not only in traditional Chinese medicine, but also in modern medicine, they have made more outstanding achievements. Special drugs for various diseases are emerging in an endless stream. Their share of the world pharmaceutical market is increasing year by year. Now even the United States

The pharmaceutical giants also had to deal with the impact of Handing Group with all their strength. Unexpectedly, they turned to the traditional Chinese medicine industry, and as soon as they came up, they produced specific medicines for Mers virus." A Korean traditional Chinese medicine expert said with shame.

Face is face, and if you can't deal with the Mers virus, then you have lost your dignity. Soon Handing Group received an order from the Koreans. Only then did they obtain the approved drug for the Mers virus in China through the special drug approval shortcut method.

The license was quickly obtained in Korea at lightning speed.

The special medicine is indeed a special medicine, and it is very effective in treating Mers patients. Many Mers patients were soon cured and discharged. This also made Handing's traditional Chinese medicine an instant success in South Korea.

The Koreans are not the only ones who are nervous. The Japanese occupy more markets in the traditional Chinese medicine market outside China. The Japanese hold most of the traditional Chinese medicine patents, many of which even come from prescriptions in ancient Chinese classics. They occupy more than South Korea.

The international market for traditional Chinese medicine has more people.

This time, Handing Group is clearly ahead of the Japanese.

Tashiro, the president of Nishimura Co., Ltd., was very dissatisfied with this situation. At the meeting, he pointed at the nose of the head of the R&D department and cursed: "This is our biggest shame. After you easily obtained the Chinese formula,

Surprisingly, we still lag behind the Chinese in research. You know, we have the most advanced traditional Chinese medicine research technology in the world. But we have failed completely."

Ando, ​​the head of the R&D department, said bravely: "President, although we have more patents than the Chinese, we are indeed lagging behind in the development of Chinese patent medicines. After all, the Chinese have resources that we cannot match. And

Now, as the price of Chinese medicinal materials gradually increases, some of our cooperative medicinal material bases are no longer willing to cooperate with us. What is even more worrying is that Handing Group is acquiring the secret recipes of some traditional Chinese medicine families at high prices. I think this

The failure was related to the Chinese secret recipe."

"These are all excuses! Ando, ​​you should be ashamed of your dereliction of duty. Handing Group seems to be making a difference in the traditional Chinese medicine market. We must pay attention to it. Of course, we can also create patents for Chinese medicine for the Chinese

Some troubles." Tashiro showed a sly smile. Nishimura Co., Ltd. has applied for a large number of patents on traditional Chinese medicine technology, which are like landmines. As long as Chinese traditional medicine companies enter the international market, they may hit mines accidentally. (Unfinished)

To be continued, please search Piaotian Literature, the novel will be better and updated faster!


This chapter has been completed!
Previous Bookshelf directory Bookmark Next